Up3D Tech Secures Nearly RMB 100 Million Series A Funding to Accelerate Global Leadership in Digital Dental Solutions

VCBeat (WeChat ID: vcbeat) has learned that Shenzhen Up3d Tech Co., Ltd. (“Up3d Tech”), a provider of comprehensive digital solutions for dentistry, recently completed an A-round financing of nearly RMB 100 million, invested by Shiyu Capital.

This marks Shenzhen Up3d Tech Co., Ltd.’s first external financing round. The funds raised will be primarily allocated to the R&D and optimization of digital dental software and hardware products; the enhancement of its dental data platform leveraging AI, big data, cloud computing, and the Internet of Things (IoT); further expansion into global markets to solidify its leading position as a provider of digital systems for dental laboratories; and the accelerated deployment of digital solutions in clinical settings.

Up3d Tech is a provider of comprehensive digital solutions for dentistry and one of the companies in China with the most complete industrial chain layout for digital denture processing.Its independently developed dental scanners (intraoral scanners and model scanners), denture design software (CAD), denture nesting software (CAM), intelligent milling systems, and intelligent sintering systems cover the entire workflow of denture fabrication, from data acquisition and processing to material machining. The company’s products offer significant advantages in performance and cost, providing users with digital solutions that deliver optimal price-to-performance ratio.

Up3d Tech is one of the earliest companies in China to independently develop CAD and CAM software for dentures.CAD and CAM software represent the technological high ground in China’s dental digitalization sector. The Up3d team began developing dental CAD software in 2011, dedicating over a decade to overcoming critical technological bottlenecks. It has now become one of the leading enterprises in this niche market both domestically and internationally, filling the gap in Chinese-made denture design software and breaking the monopoly held by overseas companies. The vast amount of data accumulated by its software enables continuous optimization of product features, with the potential to achieve intelligent design through machine learning in the future.

Up3d Tech is an international enterprise that provides systematic, multi-dimensional solutions and implementation services to more than 200 channel partners and tens of thousands of dental clinics across nearly 100 countries and regions worldwide.. Currently, the company has served nearly 3,000 dental laboratory processors in China, achieving essentially full industry coverage. Tens of thousands of domestic dental clinics and professional institutions have benefited from Up3d’s products and services.

The Up3d Tech team has been deeply engaged in the dental industry for nearly two decades, with its core members having worked together for ten years, fostering seamless collaboration and profound industry insights.。

The founder of Up3d Tech stated: Guided by a long-term development strategy, the founding team has courageously broken through the technological monopolies held by foreign manufacturers. For over a decade, they have remained deeply committed to the research and development of hardware and software, as well as platform construction. Currently, the company boasts an R&D team of nearly 200 professionals and four digital laboratories. The technology, data, distribution channels, and terminal traffic accumulated over the past ten years will better facilitate the establishment of the Up3d Dental Ecosystem and efficiently empower the entire dental industry. Meanwhile, the company’s founder added that they are highly willing to provide hardware and software interfaces to industry peers, share ecosystem benefits, and achieve effective connectivity among users, devices, and objects.

Up3d Tech’s three-year development goal is to become a global leading provider of digital solutions for the dental laboratory and clinical sectors, further enhancing the global brand recognition and market share of its products, including dental scanners (intraoral scanners and model scanners), denture design software (CAD), denture nesting software (CAM), intelligent milling machines, and intelligent sintering systems.

Up3d Tech’s long-term development strategy will center on its integrated service platform, Up3dLink, which connects patients, dentists, dental technicians, and manufacturing facilities. By leveraging digital empowerment, the platform enables functionalities such as data transmission, remote design, intelligent design, and remotely controlled processing. This approach aims to establish a digital, intelligent, and comfortable clinical environment, making communication between dentists and technicians more time-efficient and seamless, fostering more informed and amicable dentist–patient interactions, and providing the general public with more convenient and affordable dental care.

Digitalization is an inevitable trend and a hot topic in the dental industry. When discussing the impact of dental digitalization on the entire industry, the founder of Up3d stated, “Every industry deserves to be reinvented through digitalization, and the dental industry is no exception. The essence of dental digitalization can be summarized by six core keywords.”

First, information acquisition: collecting oral data and information through devices such as intraoral scanners or CT scanners; second, information expression: representing specific information in various forms; third, information storage: storing existing information in specific locations, such as local servers, the cloud, or third-party platforms; fourth, information transmission: transmitting the information; fifth, information processing: this is the core component of dental digitalization, where information is processed, typically using digital knowledge or models via computer-aided design (CAD) and layout software; sixth, information implementation at the terminal: utilizing the processed information to remotely assist or intelligently control on-site operations of milling machines or 3D printers.

Up3d’s mission is “Improving Lives with Digital Technology.” The Up3d team will both follow and shape trends, ensuring that digital dentistry truly serves the public and makes life better.

Regarding this round of investment, Cao Jian, Founding Partner of Shiyu Capital, stated“Against the backdrop of population aging and the ‘appearance economy,’ demand for dental restoration products is surging. Digital tools can reshape traditional dental diagnosis and treatment processes on the supply side, improving efficiency, reducing costs, and delivering high-value-for-money products to the public, thereby accelerating industry development. Therefore, we remain firmly bullish on the digital dentistry sector. The Up3d team boasts extensive experience in the oral healthcare industry, focuses on technological R&D, and possesses long-term strategic vision, making it the enterprise with the most comprehensive full-industry-chain layout for digital denture processing in China. Meanwhile, the company’s products have been sold to nearly 100 countries and regions worldwide, demonstrating global competitiveness. We highly recognize the company’s core capabilities and development strategy, and look forward to its emergence as a globally leading digital dental enterprise.”

“Shiyu Capital is honored to be the first institutional investor in Up3d Tech. This represents a mutual choice based on shared values and vision. Beyond providing financial support to accelerate Up3d’s business development and realize the ‘Internet of Everything’ in dentistry, we aim to leverage our industry resources to assist the company in its ongoing globalization and clinical expansion, ensuring that cost-effective, high-quality products benefit a broader population,” added Cao Jian.

Shiyu Capital specializes in equity investments within the pharmaceutical and healthcare sectors. With assets under management exceeding RMB 7 billion, it has invested in more than 40 companies. Among these, over ten enterprises—including WuXi AppTec (603259.SH/2359.HK), Allist (688578.SH), JD Health (6618.HK), Jacobio Pharmaceuticals (1167.HK), and CARsgen Therapeutics (2171.HK)—have successfully completed initial public offerings (IPOs). Committed to facilitating the transformation and upgrading of China’s pharmaceutical industry, Shiyu Capital leverages its deep industrial resources to co-create value with outstanding entrepreneurs. It has been recognized by leading professional institutions such as Zero2IPO, CVSource, CB Insights, and PharmaCube as a top private equity firm and a premier investor in the biopharmaceutical sector.